Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prevention and treatment of human metabolic syndrome including type 2 diabetes, steatohepititis and related conditions using non-absorbable, orally administered compounds

Prevention and treatment of human metabolic syndrome including type 2 diabetes, steatohepititis and related conditions using non-absorbable, orally administered compounds

US Patent 10822310 · Granted Nov 3, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthetic analogs of ecteinascidin-7432010
Analogs of Salinosporamide A2009
Proteasome inhibiting β-lactam compounds2008
Simple stereocontrolled synthesis of salinosporamide A2007
Synthetic process for an intermediate for ecteinascidin and phthalascidin compou2004
Synthesis of pseudopterosin compounds2003
Synthetic analogs of ecteinascidin-7432003
Synthesis of pseudopterosin compounds2002
Synthetic analogs of ecteinascidin-7432002
Synthetic analogs of ecteinascidin-7432000
Process for producing ecteinascidin compounds1998
Arylsulfatase inhibition and potentiation of angiostatic steroids and heparin1992